Wednesday - April 29, 2026
Landmark Study Led by Roswell Park Expert Shows Survival Benefit of Immunotherapy in Resistant Ovarian Cancer
April 10, 2026
BUFFALO, New York, April 10 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:

* * *

Landmark Study Led by Roswell Park Expert Shows Survival Benefit of Immunotherapy in Resistant Ovarian Cancer

*

BUFFALO, N.Y. -A study published today in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) significantly improved overall survival in adults with platinum-r . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products